Examkin

Soru

Zorluk: OrtaPreventive Care and Immunizations

A 12-month-old boy is brought to the pediatrician for a routine well-child visit. His medical history is significant for perinatal HIV infection. He is currently prescribed antiretroviral therapy, but his mother admits to frequently missing doses over the past few months. Recent laboratory studies show a CD4 T-lymphocyte count of 450 cells/mm³ and a CD4 percentage of 12%. The parents express concern about his physical development, noting that he is not yet able to run or kick a ball. On examination, the boy is alert and interactive. He can stand independently for a few seconds and uses a fine pincer grasp to pick up a raisin. He says "mama" and "dada" specifically and waves "bye-bye" to the clinician. He has received all previously recommended immunizations. Which of the following is the most appropriate next step in the management of this patient?

  1. Administer age-appropriate inactivated vaccines only and reassure the parents regarding his developmentCevap
  2. B
    Administer age-appropriate inactivated and live-attenuated vaccines and reassure the parents regarding his development
  3. C
    Administer age-appropriate inactivated and live-attenuated vaccines and refer the patient for a developmental evaluation
  4. D
    Administer age-appropriate inactivated vaccines only and refer the patient for a developmental evaluation
  5. E
    Defer all immunizations until his CD4 T-lymphocyte percentage improves and reassure the parents regarding his development

Cevap

The most appropriate next step is to administer age-appropriate inactivated vaccines only and reassure the parents regarding his development.
The correct action is to provide inactivated vaccines only and offer reassurance regarding development. Routine 12-month immunizations typically include inactivated vaccines (such as PCV, Hib, HepA) and live-attenuated vaccines (MMR, Varicella). However, for pediatric patients with perinatal HIV, the administration of live vaccines depends on their immune status. A CD4 percentage < 15% indicates severe immunosuppression, making live vaccines strictly contraindicated. Inactivated vaccines are safe and must be administered to protect this vulnerable patient. Regarding his development, standing alone, having a fine pincer grasp, saying specific words ("mama/dada"), and waving bye-bye are normal 12-month milestones. Running and kicking a ball are not expected until 18 to 24 months. Therefore, the parents should be reassured without needing a developmental referral.

Adım Adım Çözüm

1
Evaluate the patient's immune status and determine vaccine eligibility.
The patient has HIV with a CD4 percentage of 12%, which defines severe immunosuppression in a child under 5 years old.
Live-attenuated vaccines (e.g., MMR, Varicella) are contraindicated in severely immunocompromised patients (CD4 < 15%) due to the risk of life-threatening vaccine-strain infection.
2
Identify the appropriate vaccines to administer at this 12-month visit.
The patient should receive scheduled inactivated vaccines (e.g., PCV, Hib, HepA) but not the normally scheduled 12-month live vaccines (MMR, Varicella).
Inactivated vaccines pose no risk of disseminated infection and should be given on schedule to protect the vulnerable host.
3
Assess the patient's developmental milestones against parental expectations.
The patient can stand independently, use a fine pincer grasp, say specific words, and wave bye-bye. These are appropriate 12-month milestones.
The parents expect 18- to 24-month milestones (running, kicking a ball). Reassurance is needed, not a developmental referral, as the child is developing normally for his age.

Anahtar Kavram

In pediatric patients with HIV, live-attenuated vaccines are contraindicated if there is severe immunosuppression (CD4 percentage < 15%). Normal 12-month milestones include standing independently, a fine pincer grasp, and saying 1-3 specific words.
Bu soruyu puanla

Konular

Preventive Care and Immunizations

Bu konudan daha fazla soru